The World Health Organization has released its first global guideline on the use of Glucagon-Like Peptide-1 (GLP-1) therapies for treating obesity, recognising the condition as a chronic and relapsing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback